Scinvivo

About:

Scinvivo develops imaging technology that specializes in optical biopsy for bladder cancer diagnostics.

Top Investors: NLC, Netherlands Enterprise Agency, Santec Corporation, Innovatiefonds Noord-Holland

Description:

Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide the answer by giving urologists real time, ultra high resolution insight into the anatomical structure during diagnosis.

Total Funding Amount:

$5.39M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2016-01-01

Contact Email:

info(AT)scinvivo.com

Founders:

Marijn van Os

Number of Employees:

1-10

Last Funding Date:

2024-02-21

IPO Status:

Private

Industries: